Prevention of Renal and Vascular End Stage Disease Study (PREVEND)
The PREVEND Study is a prospective, observational cohort study, focused on assessing the impact of elevated urinary albumin loss in non-diabetic subjects on future cardiovascular and renal disease. During the period of 1997 to 1998, all inhabitants of the city of Groningen in the Netherlands aged between 28 and 75 years were asked to answer a short questionnaire and to send in a morning urine sample. A cohort of over 8,500 subjects responded and were therefore recruited into the study. At approximately 3-year intervals, participants are invited for measurements concerning their health status.
Study design
Cohort
Number of participants at first data collection
8,592 (participants)
Age at first data collection
28 - 75 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1997
Primary Institutions
University Medical Center Groningen (Universitair Medisch Centrum Groningen, UMCG)
University of Groningen (Rijksuniversiteit Groningen, UG)
Profile paper DOI
Funders
Dutch Kidney Foundation (Nierstichting)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – paper or computer assisted
- None
- None
- None
Engagement
Keywords
